Frédéric Schynts, PhD

Frédéric is a scientist with Virology, Immunology and Vaccinology background, experienced in vaccine, cell and gene therapy development from R&D to clinical phase, Business Development and Company Development strategy. Continuous learning and training on the Managerial and Entrepreneurial aspect of the Biotech Industry.

Prior experience:
• Investment Manager, Noshaq (2020-Present)
• Independent Consultant (Schynts Consulting, 2013-Present)
• Non Clinical Development Expert (EyeD Pharma, 2018-Present)
• Senior Consultant (Rommel Consulting Partners, 2013-Present)
• Project Leader (EKLO, 2013-2020)
• Director Development Intelligence (GSK Vaccines, 2010-2013)
• Project Leader Life Cycle Management of Seasonal Influenza Vaccines (GSK Vaccines, 2009-2010)
• Head of Molecular Analytics (GSK Vaccines, 2007-2009)
• Scientific Director (CER Group, 2005-2007)
• Director of the Virology Department (CER Group, 2002-2005)

Education:
• Master in Laboratory Animal Sciences (ULiège, Belgium, 2003)
• PhD in Veterinary Sciences (Virology, Immunology, and Vaccinology, ULiège Belgium, 2002)
• Visiting Scientist (Virginia Commonwealth University, USA, 2001)
• Doctor In Veterinary Medicine (ULiège, Belgium, 1996)